Binding of protein kinase inhibitors to synapsin I inferred from pair-wise binding site similarity measurements.
Predicting off-targets by computational methods is getting increasing importance in early drug discovery stages. We herewith present a computational method based on binding site three-dimensional comparisons, which prompted us to investigate the cross-reaction of protein kinase inhibitors with synapsin I, an ATP-binding protein regulating neurotransmitter release in the synapse. Systematic pair-wise comparison of the staurosporine-binding site of the proto-oncogene Pim-1 kinase with 6,412 druggable protein-ligand binding sites suggested that the ATP-binding site of synapsin I may recognize the pan-kinase inhibitor staurosporine. Biochemical validation of this hypothesis was realized by competition experiments of staurosporine with ATP-gamma(35)S for binding to synapsin I. Staurosporine, as well as three other inhibitors of protein kinases (cdk2, Pim-1 and casein kinase type 2), effectively bound to synapsin I with nanomolar affinities and promoted synapsin-induced F-actin bundling. The selective Pim-1 kinase inhibitor quercetagetin was shown to be the most potent synapsin I binder (IC50 = 0.15 microM), in agreement with the predicted binding site similarities between synapsin I and various protein kinases. Other protein kinase inhibitors (protein kinase A and chk1 inhibitor), kinase inhibitors (diacylglycerolkinase inhibitor) and various other ATP-competitors (DNA topoisomerase II and HSP-90alpha inhibitors) did not bind to synapsin I, as predicted from a lower similarity of their respective ATP-binding sites to that of synapsin I. The present data suggest that the observed downregulation of neurotransmitter release by some but not all protein kinase inhibitors may also be contributed by a direct binding to synapsin I and phosphorylation-independent perturbation of synapsin I function. More generally, the data also demonstrate that cross-reactivity with various targets may be detected by systematic pair-wise similarity measurement of ligand-annotated binding sites.
Defranchi
Enrico
E
Department of Neuroscience and Brain Technologies, The Italian Institute of Technology, Genova, Italy.
De Franchi
Enrico
E
Schalon
Claire
C
Messa
Mirko
M
Onofri
Franco
F
Benfenati
Fabio
F
Rognan
Didier
D
D000199:Actins / Q000378:metabolism; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D001665:Binding Sites; D002417:Cattle; D019295:Computational Biology / Q000379:methods*; D006801:Humans; D008024:Ligands; D008958:Models, Molecular; D011485:Protein Binding / Q000187:drug effects; D011487:Protein Conformation; D047428:Protein Kinase Inhibitors / Q000378:metabolism* / Q000494:pharmacology; D000090063:Proto-Oncogene Mas; D051573:Proto-Oncogene Proteins c-pim-1 / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000378:metabolism; D019311:Staurosporine / Q000378:metabolism / Q000494:pharmacology; D016704:Synapsins / Q000737:chemistry / Q000378:metabolism*
D000199:Actins; D008024:Ligands; C000715470:MAS1 protein, human; D047428:Protein Kinase Inhibitors; D000090063:Proto-Oncogene Mas; D016704:Synapsins; D000255:Adenosine Triphosphate; D051573:Proto-Oncogene Proteins c-pim-1; D019311:Staurosporine
J Mol Biol. 2006 Feb 3;355(5):1112-24
16359705
J Chem Inf Model. 2006 Nov-Dec;46(6):2725-36
17125212
EMBO J. 1998 Feb 16;17(4):977-84
9463376
Expert Opin Drug Metab Toxicol. 2008 Mar;4(3):273-80
18363542
J Med Chem. 2002 Sep 12;45(19):4350-8
12213076
Nat Biotechnol. 2005 Mar;23(3):329-36
15711537
J Neurosci. 2001 Oct 15;21(20):7944-53
11588168
Neuron. 2003 Apr 10;38(1):69-78
12691665
Curr Opin Chem Biol. 2001 Aug;5(4):464-70
11470611
J Biol Chem. 1971 Aug 10;246(15):4866-71
4254541
Science. 2002 Dec 6;298(5600):1912-34
12471243
Chembiochem. 2005 May;6(5):876-89
15791686
Nature. 2009 Nov 12;462(7270):175-81
19881490
Proteins. 2008 Jun;71(4):1755-78
18175308
Chem Biol. 2007 Nov;14(11):1207-14
18022559
J Med Chem. 2005 Apr 7;48(7):2534-47
15801843
Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5441-6
18385384
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4617-22
19255428
Annu Rev Cell Biol. 1990;6:433-60
1980418
J Chem Inf Model. 2006 Mar-Apr;46(2):717-27
16563002
Nat Biotechnol. 2007 Feb;25(2):197-206
17287757
J Biol Chem. 1998 May 29;273(22):13371-4
9593663
Nature. 1970 Aug 15;227(5259):680-5
5432063
J Neurosci. 2005 Mar 9;25(10):2658-69
15758176
Nature. 1992 Oct 1;359(6394):417-20
1328883
J Cell Biol. 1995 Mar;128(5):905-12
7876313
J Biol Chem. 1998 Jan 16;273(3):1425-9
9430678
Protein Sci. 2006 Sep;15(9):2071-81
16882991
J Biol Chem. 2005 Sep 2;280(35):31208-19
15975926
PLoS Comput Biol. 2009 Jul;5(7):e1000423
19578428
J Mol Biol. 2004 Jun 4;339(3):607-33
15147845
Mol Inform. 2010 Mar 15;29(3):176-87
27462761
J Struct Funct Genomics. 2009 Apr;10(2):181-91
19194785
J Biol Chem. 2002 Jul 12;277(28):25493-501
11964410
J Proteomics. 2009 Apr 13;72(3):567-73
19084081
Q Rev Biophys. 2009 Feb;42(1):1-40
19296866
Nat Chem Biol. 2008 Nov;4(11):682-90
18936753
J Biol Chem. 2007 May 25;282(21):15754-67
17400547
Nucleic Acids Res. 2000 Jan 1;28(1):235-42
10592235
PLoS Comput Biol. 2007 Nov;3(11):e217
18052534
Angew Chem Int Ed Engl. 2009;48(1):104-9
19016294
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12079-84
19581596
Curr Pharm Des. 2005;11(27):3545-59
16248807
Br J Pharmacol. 2007 Sep;152(1):38-52
17533416
Structure. 2009 Jun 10;17(6):869-81
19523904
J Chem Inf Model. 2010 Jan;50(1):123-35
20058856
J Chem Inf Model. 2006 May-Jun;46(3):1124-33
16711732
Science. 1989 Sep 29;245(4925):1474-80
2506642
Nature. 2004 Dec 16;432(7019):862-5
15602552
J Neurosci. 2006 Nov 8;26(45):11670-81
17093089
J Med Chem. 2006 Nov 16;49(23):6768-78
17154507
BMC Bioinformatics. 2008 Dec 17;9:543
19091072
J Med Chem. 2006 Nov 16;49(23):6802-10
17154510
Br J Pharmacol. 2007 Sep;152(1):9-20
17549047
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W623-33
19498078
Nat Biotechnol. 2006 Jul;24(7):805-15
16841068
Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3679-83
8622996
Cell Mol Life Sci. 2009 Apr;66(7):1163-77
19011754
J Med Chem. 2004 Jun 3;47(12):2977-80
15163179
Chem Cent J. 2007 Mar 13;1:7
17880740
Proteins. 2004 Mar 1;54(4):671-80
14997563
Neuron. 1992 Feb;8(2):377-86
1739463
J Biol Chem. 2004 Mar 19;279(12):11948-56
14688264
J Neurochem. 2005 Jun;93(6):1401-11
15935056
PLoS Comput Biol. 2010 Jan 22;6(1):e1000648
20098496
J Chem Inf Model. 2008 May;48(5):1014-25
18412328
J Biol Chem. 1999 Jun 11;274(24):16747-53
10358015
J Biol Chem. 2002 Nov 22;277(47):45473-9
12237306
J Biol Chem. 1992 Jun 5;267(16):11281-8
1317863
J Med Chem. 2007 Nov 15;50(23):5571-8
17902636
Curr Opin Chem Biol. 2008 Jun;12(3):352-8
18312862
Nat Neurosci. 2002 May;5(5):431-7
11976703
J Biol Chem. 1985 Feb 10;260(3):1696-704
3968085
Brain Cell Biol. 2006 Jun;35(2-3):107-15
17957477
Nucleic Acids Res. 2006 Jul 1;34(Web Server issue):W219-24
16844997
Angew Chem Int Ed Engl. 2008;47(1):48-56
18080276
J Med Chem. 2004 Jun 3;47(12):3032-47
15163185
Curr Drug Discov Technol. 2005 Sep;2(3):161-7
16472225
Nat Neurosci. 2001 Dec;4(12):1187-93
11685225
J Cell Biol. 1989 May;108(5):1841-9
2497104
Bioinformatics. 2009 Jun 15;25(12):i296-304
19478002
Biochem Biophys Res Commun. 1980 Sep 16;96(1):18-27
6893667
Drug Discov Today. 2006 Apr;11(7-8):348-54
16580977
J Exp Zool. 1999 Dec 15;285(4):360-77
10578110
Proteins. 2001 May 1;43(2):217-26
11276090
J Biol Chem. 2005 Sep 2;280(35):31220-9
15985434
Science. 1993 Feb 5;259(5096):780-5
8430330
PLoS Comput Biol. 2009 Jul;5(7):e1000441
19629158
J Neurosci. 2005 Aug 10;25(32):7299-308
16093379
Nature. 1987 Apr 16-22;326(6114):704-7
3104800
Cancer Res. 2005 Jan 15;65(2):379-82
15695376